通过热遗传学为基础的CXCL12生成器激活PerC B细胞,用于对转移性传播瘤细胞的腹腔内免疫
Zhiwei Yin1, Ling Li1,2, Qiang Zhang1,3
1Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Environmental Science and Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, 410082, China.
Advanced materials (Deerfield Beach, Fla.)
|January 27, 2025
概括
这项研究引入了一种新的腹腔内免疫疗法 (IPIT),可以激活B细胞进行癌症免疫,绕过常规细胞. 这种新方法有效地向扩散的瘤细胞,并减少腹转移.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 在腹膜转移 (PM) 中,常规的抗原呈现细胞促进瘤生长和免疫抑制.
- 腹腔内免疫疗法 (IPIT) 对PM有前途,但由于对腹腔内免疫细胞的理解不足,其受限.
- 需要一个树突细胞独立的IPIT来克服当前的局限性.
研究的目的:
- 开发下一代IPIT激活腹腔腔B (PerC B) 细胞以获得抗瘤免疫力.
- 为了研究PerC B细胞在癌症治疗的外源抗原呈现中的作用.
- 建立一个可编程招募扩散瘤细胞 (DTC) 和随后免疫激活的框架.
主要方法:
- 开发一种基于热遗传学的CXCL12发生器,用于招募DTC.
- 使用纳米级生成器控制CXCL12表达并避免细胞因子风暴.
- 单细胞RNA测序以识别关键的PerC B细胞子集和信号分子 (Ptpn6, Ms4a1, Cd52).
主要成果:
- 开发的IPIT框架成功地激活了用于抗瘤免疫力的PerC B细胞.
- 该系统通过CXCL12-CXCR4轴有效地招募DTC.
- 确定了与治疗反应有关的关键抗原呈现B细胞集群.
- 在胃癌模型中显著降低了腹膜溢出和PM.
结论:
- 这项工作介绍了一种新的PerC B细胞参与的机制,用于腹腔内抗原呈现.
- 开发的IPIT战略提供了一个可配置的方法来激活反DTC免疫力.
- 这项研究为下一代腹腔内癌免疫疗法提供了一个有希望的途径.
相关概念视频
01:27Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
01:24B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K